|
|
 |
|
|
|
SCIENCE NEWS
Researchers Use Nanoparticle "Vaccine" to Cure Type 1 Diabetes in Mice
Using an innovative nanotechnology-based "vaccine," researchers were able to successfully restore normal blood sugar in mice with type 1 diabetes, and also slow the onset of diabetes in mice at risk for the disease. [Press release from Juvenile Diabetes Research Foundation discussing online prepublication in Immunity]
University of Central Florida Professor Harnesses Plant 'Power' to Fight Hemophilia
Treating hemophilia can sometimes be deadly because many patients suffer fatal allergic reactions to the expensive protein that doctors use to make their blood clot. Now researchers have devised a way that could help patients develop a tolerance to the therapeutic protein before they seek treatment to prevent the potentially deadly reactions. [Press release from University of Central Florida discussing online prepublication in Proceedings of the National Academy of Sciences U S A]
|
|
INDUSTRY NEWS
US Seeks to Make Science Free For All
Moves to make research funded by the US government available to everyone could mark a turning point in a publishing revolution. [Nature News]
CureDM Partners Novel Diabetes Treatment With Sanofi-Aventis
CureDM, LLC announced that an agreement has been signed with Sanofi-Aventis for the exclusive worldwide license of Pancreate™, a novel islet neogenesis agent for the treatment of type 1 and type 2 diabetes. [CureDM, LLC. Press Release]
Portola Pharmaceuticals Announces Initiation of Phase I Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications
Portola Pharmaceuticals, Inc. announced that it has initiated its first in human Phase I trial in healthy volunteers of PRT062607, a novel, oral Syk-specific kinase inhibitor in development to treat chronic inflammatory diseases, including rheumatoid arthritis, and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. [Portola Pharmaceuticals, Inc. Press Release]
|
|
POLICY NEWS
Enhancing Peer Review: Updated Processes for the Review of All Ruth L. Kirschstein National Research Service Award Fellowship Applications (NOT-OD-10-071) [National Institutes of Health, United States]
NIH Will Require the Electronic Submission of Appointment Forms and Termination Notices via xTrain for Research Training, Fellowship, Education, and Career Awards Beginning January 2011 (NOT-OD-10-072) [National Institutes of Health, United States]
Small Business Innovation Research Award Levels Adjusted to $150,000 (Phase I) and $1,000,000 (Phase II) (NOT-OD-10-079) [National Institutes of Health, United States]
Notice of Change in Expiration Date for Program Announcement on Bioengineering Research Partnerships (PAR-07-352) (NOT-EB-10-001) [National Institutes of Health, United States]
Revision of the Requirements for Constituent Materials (Docket No. FDA-2010-N-0099) [Food and Drug Administration, United States]
Voting and Nonvoting Consumer Representative Members on Public Advisory Committees and Panels; Notice of Public Meeting (Docket No. FDA-2010-N-0001) [Food and Drug Administration, United States]
Determination of Regulatory Review Period for Purposes of Patent Extension; LUSEDRA (Docket Nos. FDA-2009-E-0202 and FDA-2009-E-0204) [Food and Drug Administration, United States]
Revision of Organization and Conforming Changes to Regulations (Docket No. FDA-2010-N-0148) [Food and Drug Administration, United States]
Administrative Practices and Procedures; Good Guidance Practices; Technical Amendment (Docket No. FDA-1999-N-3539) [Food and Drug Administration, United States]
2010 Biological License Application Supplement Noteworthy Approvals [Food and Drug Administration, United States]
|
|
EVENTS
American Association for Cancer Research (AACR) 101st Annual Meeting 2010
April 17-21, 2010
Washington, DC, United States
23rd Annual Canadian Society for Immunology (CSI) Conference
April 23-26, 2010
Niagara Falls, Canada
97th Annual Meeting of the American Association of Immunologists (AAI)
May 7-11, 2010
Baltimore, United States
29th Congress of the European Academy of Allergy and Clinical Immunology (EAACI)
June 5-9, 2010
London, United Kingdom
Keystone Symposia: Innate Immunity - Mechanisms Linking with Adaptive Immunity (D3)
June 7-12, 2010
Dublin, Ireland
Federation of Clinical Immunology Societies (FOCIS) 2010
June 24-27, 2010
Boston, United States
Frontiers in Immunology Research (FIRN) 2010 International Conference
July 22-26, 2010
Athens, Greece
14th International Congress of Immunology
August 22-27, 2010
Kobe, Japan
7th Annual RNAi & miRNA Europe Select BioSciences
September 14-15, 2010
Dublin, Ireland
5th International Conference on Gene Regulation in Lymphocyte Development
October 9-14, 2010
Chania, Greece
Autumn Immunology Conference 2010
November 19-22, 2010
Chicago, United States
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization's career opportunities with Cell Therapy News.
Visit here to post your career opportunities.
Have we missed an important article or publication in Immune Regulation News? Click here to submit!
|
|
|
|
|
|
|
|
|
